Literature DB >> 17210698

Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.

Millicent Winner1, Albert C Koong, Beatriz E Rendon, Wayne Zundel, Robert A Mitchell.   

Abstract

Low oxygen tension-mediated transcription by hypoxia-inducible factors (HIF) has been reported to facilitate tumor progression, therapeutic resistance, and metastatic adaptation. One previously described target of hypoxia-mediated transcription is the cytokine/growth factor macrophage migration inhibitory factor (MIF). In studies designed to better understand hypoxia-stimulated MIF function, we have discovered that not only is MIF induced by hypoxia in pancreatic adenocarcinoma but MIF is also necessary for maximal hypoxia-induced HIF-1alpha expression. Cells lacking MIF are defective in hypoxia- and prolyl hydroxylase inhibitor-induced HIF-1alpha stabilization and subsequent transcription of glycolytic and angiogenic gene products. Moreover, COP9 signalosome subunit 5 (CSN5), a component of the COP9 signalosome previously reported to functionally interact with MIF, has recently been shown to interact with and stabilize HIF-1alpha. Our results indicate that MIF interacts with CSN5 in pancreatic cancer cells and that MIF-depleted cells display marked defects in hypoxia-induced CSN5/HIF-1alpha interactions. This functional interdependence between HIF-1alpha and MIF may represent an important and previously unrecognized pro-tumorigenic axis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210698      PMCID: PMC2941512          DOI: 10.1158/0008-5472.CAN-06-3292

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

1.  Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas.

Authors:  Chia-Tung Shun; Jaw-Town Lin; Shih-Pei Huang; Min-Tsan Lin; Ming-Shiang Wu
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

2.  HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

Authors:  H E Ryan; J Lo; R S Johnson
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

3.  Intracellular interaction of myosin light chain kinase with macrophage migration inhibition factor (MIF) in endothelium.

Authors:  Raj Wadgaonkar; Steven M Dudek; Ari L Zaiman; Laura Linz-McGillem; Alexander D Verin; Saule Nurmukhambetova; Lewis H Romer; Joe G N Garcia
Journal:  J Cell Biochem       Date:  2005-07-01       Impact factor: 4.429

Review 4.  Hypoxia in head and neck cancer: how much, how important?

Authors:  H L Janssen; K M Haustermans; A J Balm; A C Begg
Journal:  Head Neck       Date:  2005-07       Impact factor: 3.147

5.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.

Authors:  K Tomoda; Y Kubota; J Kato
Journal:  Nature       Date:  1999-03-11       Impact factor: 49.962

6.  Rho GTPase-dependent signaling is required for macrophage migration inhibitory factor-mediated expression of cyclin D1.

Authors:  James D Swant; Beatriz E Rendon; Marc Symons; Robert A Mitchell
Journal:  J Biol Chem       Date:  2005-04-19       Impact factor: 5.157

7.  Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.

Authors:  Yi Ren; Simon Law; Xin Huang; Ping Yin Lee; Michael Bacher; Gopesh Srivastava; John Wong
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

8.  Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway.

Authors:  Bailong Sun; Jun Nishihira; Takashi Yoshiki; Masao Kondo; Yuji Sato; Fumiaki Sasaki; Satoru Todo
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

9.  Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules.

Authors:  Benjamin J Moeller; Yiting Cao; Chuan Y Li; Mark W Dewhirst
Journal:  Cancer Cell       Date:  2004-05       Impact factor: 31.743

10.  A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter.

Authors:  G Melillo; T Musso; A Sica; L S Taylor; G W Cox; L Varesio
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  39 in total

Review 1.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

2.  Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.

Authors:  Naotake Funamizu; Chaoxin Hu; Curtis Lacy; Aaron Schetter; Geng Zhang; Peijun He; Jochen Gaedcke; Michael B Ghadimi; Thomas Ried; Harris G Yfantis; Dong H Lee; Jeffrey Subleski; Tim Chan; Jonathan M Weiss; Timothy C Back; Katsuhiko Yanaga; Nader Hanna; H Richard Alexander; Anirban Maitra; S Perwez Hussain
Journal:  Int J Cancer       Date:  2013-02-15       Impact factor: 7.396

3.  Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.

Authors:  Leona Mawhinney; Michelle E Armstrong; Ciaran O' Reilly; Richard Bucala; Lin Leng; Gunter Fingerle-Rowson; Darren Fayne; Michael P Keane; Aisling Tynan; Lewena Maher; Gordon Cooke; David Lloyd; Helen Conroy; Seamas C Donnelly
Journal:  Mol Med       Date:  2015-04-16       Impact factor: 6.354

Review 4.  The emerging roles of Jab1/CSN5 in cancer.

Authors:  Lin Wang; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  Med Oncol       Date:  2016-07-13       Impact factor: 3.064

5.  Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators.

Authors:  Steve Oghumu; Thomas J Knobloch; Cesar Terrazas; Sanjay Varikuti; Jennifer Ahn-Jarvis; Claire E Bollinger; Hans Iwenofu; Christopher M Weghorst; Abhay R Satoskar
Journal:  Int J Cancer       Date:  2016-06-16       Impact factor: 7.396

Review 6.  Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation.

Authors:  Millicent Winner; Lin Leng; Wayne Zundel; Robert A Mitchell
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

7.  Suppression of Jab1 expression inhibits proliferation and promotes apoptosis of AMC-HN-8 cells.

Authors:  Pei-Hua Li; Lin Wang; Yao-Jie Pan; Miao-Miao Sang; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  Oncol Lett       Date:  2018-02-06       Impact factor: 2.967

8.  Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential.

Authors:  Hui Liu; Gang Chen; Wei Zhang; Jun-Yi Zhu; Zhao-Quan Lin; Zhong-Cheng Gong; Feng-Qin Wang; Jun Jia; Zhi-Jun Sun; Yi-Fang Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-12       Impact factor: 4.553

Review 9.  Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.

Authors:  Beatriz E Rendon; Sharon S Willer; Wayne Zundel; Robert A Mitchell
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

Review 10.  Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link.

Authors:  H Conroy; L Mawhinney; S C Donnelly
Journal:  QJM       Date:  2010-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.